Intersect ENT, a subsidiary of Medtronic, is a health care equipment company based in Menlo Park, California.[2] It manufactures drug-delivery devices used by Ear, Nose & Throat (ENT) clinicians in the treatment of sinusitis. Intersect ENT is best known for developing the first bioabsorbable drug-eluting sinus stent PROPEL, which delivers anti-inflammatory medication directly to the sinuses.[5] The company holds over 20 issued patents in the United States and more than 80 patents and patent applications worldwide.[6] The company was named on the Forbes list of America's Most Promising Companies and was also on the Fierce 15 list of Most Promising Companies in 2013.[7][8]